The Application Value of Deep Learning-Based Nomograms in Benign-Malignant Discrimination of TI-RADS Category 4 Thyroid Nodules
1 other identifier
observational
500
1 country
1
Brief Summary
This retrospective study focuses on benign and malignant classification of thyroid nodules using deep learning techniques and evaluates the value of deep learning based nomograms in the classification of TI-RADS category 4 thyroid nodules to improve the accuracy of benign and malignant identification of TI-RADS category 4 thyroid nodules. Materials and methods: Patients who visited in The First Affiliated Hospital of Shandong First Medical University & Shandong Provincial Qianfoshan Hospital were collected. Their general clinical features, information on preoperative ultrasound diagnosis, and postoperative pathologic data were reviewed.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Apr 2022
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
November 30, 2023
CompletedStudy Completion
Last participant's last visit for all outcomes
November 30, 2023
CompletedFirst Submitted
Initial submission to the registry
January 4, 2024
CompletedFirst Posted
Study publicly available on registry
February 14, 2024
CompletedFebruary 14, 2024
February 1, 2024
1.7 years
January 4, 2024
February 5, 2024
Conditions
Keywords
Outcome Measures
Primary Outcomes (4)
deep learning prediction model(YOLOv3) and the model evaluation
Based on the characteristics of benign and malignant thyroid nodules, the dataset was divided into a training set and a test set using the cross-validation method, and the YOLOv3 model was trained using data from the training set, and the performance of the model was evaluated using data from the test set.The model is evaluated using a number of metrics such as: precision-recall curve, effective classification precision, confusion matrix and area under the curve.
Immediately evaluated after the prediction model was built
nomogram prediction and assessment
Factoring clinical features, ultrasound grading and model predictions to map nomograms using R language.Evaluation of the nomogram using various metrics, including subject operating characteristic curves, calibration curves and decision curve analysis
Immediately evaluated after the nomogram was built
Selection of clinical features and assessment
The researchers selected patients with TI-RADS category 4 thyroid nodules within 1 year to comprise the dataset. The researchers analyzed the clinical factors in the dataset and analyzed the significance of these clinical factors on the statistical results and clinical characteristics using the Wilcoxon two-sample rank sum test or chi-square test.
After the dataset is collected and pathology results are obtained, the statistical results obtained are analyzed for clinical factors, averaging about 1 year.
Impact and assessment of ultrasound grading
The researchers selected patients with TI-RADS category 4 thyroid nodules within 1 year to comprise the dataset. The researchers analyzed the results of grading TI-RADS category 4 nodules in this dataset and determined the significance of ultrasound grading on the statistical results using the chi-square test.
The graded results of the ultrasound examination were analyzed after the data set collection was completed, the ultrasound examination was completed and the final pathology results were obtained, on average about 1 year.
Study Arms (2)
maligant
Thyroid nodules with surgical or puncture biopsy-confirmed pathological findings of malignancy in the TI-RADS4 category
benign
Thyroid nodules with surgical or puncture biopsy-confirmed pathological findings of benign TI-RADS4 category
Eligibility Criteria
The study collected data on a total of 500 TI-RADS category 4 thyroid nodules from 500 patients who attended the First Affiliated Hospital of Shandong First Medical University from April 2022 to November 2023.
You may qualify if:
- Ultrasound-confirmed diagnosis of thyroid nodules that are classified as TI-RADS category 4.
- Availability of pathological results.
You may not qualify if:
- Lack of pathological diagnosis.
- History of thyroid surgery or other treatments.
- Poor quality of ultrasound images of thyroid nodules.
- Incomplete clinical and imaging data of the patient.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Ma Zhelead
Study Sites (1)
QianfoshanH
Jinan, Shandong, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- RETROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Director of Ultrasound
Study Record Dates
First Submitted
January 4, 2024
First Posted
February 14, 2024
Study Start
April 1, 2022
Primary Completion
November 30, 2023
Study Completion
November 30, 2023
Last Updated
February 14, 2024
Record last verified: 2024-02
Data Sharing
- IPD Sharing
- Will not share